Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
oxytetracyclin + lidocain 125 mg/ml/2 % injektionsvæske, 2 ml ampul |
Is a |
Product containing oxytetracycline (medicinal product) |
false |
Inferred relationship |
Some |
|
|
oxytetracyclin + lidocain 125 mg/ml/2 % injektionsvæske, 2 ml ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Oxytetracycline (substance) |
false |
Inferred relationship |
Some |
|
|
oxytetracyclin + lidocain 125 mg/ml/2 % injektionsvæske, 2 ml ampul |
Is a |
Product containing lidocaine and oxytetracycline (medicinal product) |
false |
Inferred relationship |
Some |
|
|
oxytetracyclin + lidocain 125 mg/ml/2 % injektionsvæske, 2 ml ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Lidocaine (substance) |
false |
Inferred relationship |
Some |
|
|
oxytetracyclin + lidocain 125 mg/ml/2 % injektionsvæske, 2 ml ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Baktericid |
false |
Inferred relationship |
Some |
|
|
oxytetracyclin + lidocain 125 mg/ml/2 % injektionsvæske, 2 ml ampul |
Has manufactured dose form |
injektionsvæske |
false |
Inferred relationship |
Some |
|
|
oxytetracyclin + lidocain 125 mg/ml/2 % injektionsvæske, 2 ml ampul |
Is a |
Product containing oxytetracycline in parenteral dose form (medicinal product form) |
false |
Inferred relationship |
Some |
|
|
oxytetracyclin + lidocain 125 mg/ml/2 % injektionsvæske, 2 ml ampul |
Is a |
Lidocaine-containing product in parenteral dose form |
false |
Inferred relationship |
Some |
|
|